Drug Profile
2-Methoxyestradiol - PR Pharmaceuticals
Alternative Names: 2ME - PR Pharmaceuticals; PulmoLARLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator PR Pharmaceuticals
- Class Antineoplastics; Estradiol congeners; Estrenes; Small molecules
- Mechanism of Action Epoprostenol agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pulmonary arterial hypertension
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Pulmonary-arterial-hypertension in USA (SC, Injection)
- 29 Mar 2006 Phase-I clinical trials in Pulmonary arterial hypertension in USA (SC)